Acquisition (Additional Information) (Details) - USD ($) $ in Thousands		3 Months Ended
		Jun. 30, 2023	Jun. 30, 2022
Business Acquisition [Line Items]
Income tax benefit		$ 0	$ 254
Recognized revenue	[1]	60,864	64,513
Net income (loss)		(104,624)	(89,532)
Class A Common Stock [Member]
Business Acquisition [Line Items]
Net income (loss)		$ (66,563)	$ (48,584)

[1] There was no Therapeutics revenue for the three months ended June 30, 2023 and 2022.